Montréal, Quebec, Canada In 1991 was created Cognicase, which is appeared as Corporate Investor. The company was established in North America in Canada. The main office of represented Corporate Investor is situated in the Montru00e9al.
The important activity for fund was in 2000. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 1 - 5 millions dollars.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular portfolio startups of the fund, we may highlight Datacom. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. Among the most popular fund investment industries, there is Developer Tools.
The typical case for the fund is to invest in rounds with 3 participants. The meaningful sponsors for the fund in investment in the same round are Hu00e9lu00e8ne Desmarais, Emerge Capital. In the next rounds fund is usually obtained by I-U-Go Ventures, Vimac Ventures, Investissement Desjardins.
| Fund Name | Location |
| Aju Pharma | - |
| Carefusion | California, San Diego, United States |
| EMV Capital | England, London, United Kingdom |
| Health Innovation Fund | California, Oakland, United States |
| Libertas Capital | Beverly Hills, California, United States |
| Media General | Sandston, United States, Virginia |
| Ozone Ventures | - |
| Penu Investments | - |
| Suzhou Youcai Huiying Investment Center | China, Jiangsu, Suzhou |
| Vestinwolf Alternatives | England, London, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 